We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.
| Share Name | Share Symbol | Market | Type |
|---|---|---|---|
| Intuitive Surgical Inc | NASDAQ:ISRG | NASDAQ | Common Stock |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 380.37 | 380.00 | 384.45 | 0 | 01:00:00 |
From May 2022 to May 2024
By Will Feuer
Intuitive Surgical Inc. said the U.S. Food and Drug Administration has cleared its da Vinci SP surgical system for simple prostatectomy, in which a surgeon removes part of an enlarged prostate.
The FDA also cleared the da Vinci SP surgical system for use in transvesical approaches to both simple and radical prostatectomies, the company said. In a radical prostatectomy, the surgeon removes the entire prostate gland, usually for patients who have been diagnosed with prostate cancer.
"There is a growing body of clinical evidence on the use of the SP system, and we look forward to continuing our efforts to safely advance minimally invasive surgery," Chief Medical Officer Myriam Curet said.
Intuitive Surgical's da Vinci SP system provides surgeons with robotic-assisted technology designed for deep and narrow access to tissue in the body.
Write to Will Feuer at Will.Feuer@wsj.com
(END) Dow Jones Newswires
April 28, 2023 08:39 ET (12:39 GMT)
Copyright (c) 2023 Dow Jones & Company, Inc.
1 Year Intuitive Surgical Chart |
1 Month Intuitive Surgical Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
